Colonic Gene Expression and Fecal Microbiota in Diarrhea-predominant Irritable Bowel Syndrome: Increased Toll-like Receptor 4 but Minimal Inflammation and no Response to Mesalazine. (2021)
Attributed to:
Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome(IBS-D)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.5056/jnm20205
PubMed Identifier: 33795545
Publication URI: http://europepmc.org/abstract/MED/33795545
Type: Journal Article/Review
Volume: 27
Parent Publication: Journal of neurogastroenterology and motility
Issue: 2
ISSN: 2093-0879